KIORA PHARMACEUTICALS INC (KPRX, KPHMW) (CIK 0001372514) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001372514-25-000074
- Form
- CORRESP
- Filer
- KIORA PHARMACEUTICALS INC (KPRX, KPHMW) (CIK 0001372514)
- CIK
- 0001372514
- Ticker
- KPRX, KPHMW
- Filed
- 2025-09-17
- SIC industry
- 2834
- HQ
- Encinitas, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000074/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer